New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. ÌýYou can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
WELCOME BACK
ACR Appropriateness Criteria (R) Adjuvant Management of Early-Stage Endometrial Cancer
ÌÇÐÄ´«Ã½
ACR Appropriateness Criteria (R) Adjuvant Management of Early-Stage Endometrial Cancer ONCOLOGY-NEW YORK Wahl, A. O., Gaffney, D. K., Jhingran, A., Yashar, C. M., Biagioli, M., Elshaikh, M. A., Jolly, S., Kidd, E., Lee, L. J., Li, L., Moore, D. H., Rao, G. G., Williams, N. L., Small, W. 2016; 30 (9): 816-822Abstract
These consensus guidelines on adjuvant radiotherapy for early-stage endometrial cancer were developed from an expert panel convened by the American College of Radiology. The American College of Radiology Appropriateness Criteria® are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer-reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method; and Grading of Recommendations Assessment, Development, and Evaluation, or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment. After a review of the published literature, the panel voted on three variants to establish best practices for the utilization of imaging, radiotherapy, and chemotherapy after primary surgery for early-stage endometrial cancer.
View details for
View details for